Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China · Delayed Price · Currency is CNY 10.84
+0.14 (1.31%)
May 19, 2026, 10:15 AM CST
SHE:301060 Market Cap
SHE:301060 has a market cap or net worth of 4.26 billion as of May 18, 2026. Its market cap has increased by 22.74% in one year.
Market Cap
4.26B
Enterprise Value
3.67B
Revenue
1.38B
Ranking
n/a
PE Ratio
289.78
Stock Price
10.84
Market Cap Chart
Since September 13, 2021, SHE:301060's market cap has decreased from 7.32B to 4.26B, a decrease of -41.73%. That is a compound annual growth rate of -10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 4.26B | 15.68% |
| Dec 31, 2025 | 3.69B | 1.45% |
| Dec 31, 2024 | 3.63B | -31.73% |
| Dec 29, 2023 | 5.32B | -32.23% |
| Dec 30, 2022 | 7.85B | -43.54% |
| Dec 31, 2021 | 13.91B | 90.09% |
| Sep 13, 2021 | 7.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 7.76B |
| Shanghai Runda Medical Technology | 7.73B |
| Beijing Strong Biotechnologies,Inc. | 7.61B |
| Maccura Biotechnology Co.Ltd | 6.25B |
| Cowealth Medical China | 5.94B |
| Thalys Medical Technology Group | 4.56B |
| SMO ClinPlus CO.,LTD. | 3.98B |
| Guangdong Hybribio Biotech | 3.96B |